Vilnius, Lithuania

Ignas Mazelis


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ignas Mazelis: Innovator in Catalytic Biomolecule Characterization

Introduction

Ignas Mazelis is a prominent inventor based in Vilnius, Lithuania. He has made significant contributions to the field of biomolecular research, particularly in the characterization of catalytic biomolecules. His innovative work has implications for various applications in biotechnology and molecular biology.

Latest Patents

Ignas Mazelis holds a patent for a groundbreaking invention titled "Catalytic biomolecule activity recording into DNA sequence." This invention relates to the characterization of catalytic biomolecules and microfluidics. It is designed for the identification of nucleic acids encoding active catalytic molecules within a plurality of nucleic acids. The technology gathers information about catalytic biomolecule activity and explores different properties of regulating sequences that modulate the expression of these molecules. This is achieved by recording the information into the DNA sequence of the same catalytic biomolecule using advanced microfluidic techniques. He has 1 patent to his name.

Career Highlights

Throughout his career, Ignas has worked with notable institutions, including Vilnius University and UAB Biomatter Designs. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biomolecular research.

Collaborations

Ignas has collaborated with talented individuals such as Laurynas Karpus and Irmantas Rokaitis. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Ignas Mazelis is a distinguished inventor whose work in catalytic biomolecule characterization has the potential to revolutionize the field of biotechnology. His innovative patent and collaborations highlight his commitment to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…